Jonathan E Lim

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Feb 25	MAZE Maze Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	270,232	0.00	307,956
3 Feb 25	MAZE Maze Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	37,724	0.00	37,724
3 Feb 25	MAZE Maze Therapeutics	Series B Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	2,231,381	0.00	0
3 Feb 25	MAZE Maze Therapeutics	Series A Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	363,703	0.00	0
3 Feb 25	ERAS Erasca	Stock option Common Stock	Grant	Acquire A	No	No	1.76	2,500,000	4.40 mm	2,500,000
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	10.42	9,086	94.68 k	9,086
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Sale back to company	Dispose D	No	No	17.74	5,704	101.19 k	0
9 Dec 24	MAZE Maze Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	10.42	5,704	59.44 k	5,704
20 Jun 24	BOLD Boundless Bio, Inc. Common Stock	Stock Option Common Stock	Grant	Acquire A	No	No	5.5	6,610	36.35 k	6,610
20 Jun 24	ERAS Erasca	Stock Option Common Stock	Grant	Acquire A	No	No	2.03	632,759	1.28 mm	632,759

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.